Skip to content
Biodatica
Start free

GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC

NISKAYUNA, NY

OncologyPhase I
Compare Sign in to watch

What changed

NIH R21 · $0.2M · Integrating Radiologist Insights for Safe and Accurate AI-Assisted Prostate MRI Interpretation

5w agoGrant renewalJun 9, 2026Source filing (opens the source filing in a new tab)

Momentum

64no change

Momentum 64 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase I

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

847 pre-ticker oncology companies at Phase I

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R21 · $184k · non-dilutive

    Jun 1, 2025

    UNIVERSITY OF DELAWARE · PI PENG, XI · NCI · award ends May 31, 2027 · Integrating Radiologist Insights for Safe and Accurate AI-Assisted Prostate MRI Interpretation

    NIH RePORTER · NIH RePORTER 11320728 (opens the source filing in a new tab)

  2. Grant

    U01 · $1.1M · non-dilutive

    Sep 1, 2023

    GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC · PI FOO, THOMAS K · NIBIB · award ends Aug 31, 2028 · Enabling clinical tissue microstructure imaging as a diagnostic tool in wide-bore 3T MRI

    NIH RePORTER · NIH RePORTER 11145170 (opens the source filing in a new tab)

  3. Trial

    PHASE1 registered

    May 13, 2021

    Gynecologic Cancer · ACTIVE_NOT_RECRUITING · sponsor: Memorial Sloan Kettering Cancer Center · Novel Imaging Technique to Assess Gynecologic Cancer

    ClinicalTrials.gov · NCT04893434 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources